Showing results (271-280 of 342) with videos related to

Sort By:
Pageof 35
Cerebrovascular Diseases (Basel, Switzerland)|July 1, 2025
Enlarged Translesional Pressure Gradient Drives Recruitment of Leptomeningeal Collaterals in Medically Treated Patients with Symptomatic Middle Cerebral Artery StenosisYuying Liu, Xuan Tian, Jill Abrigo, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|April 9, 2024
Hong Kong consensus recommendations on the management of pancreatic ductal adenocarcinomaS L Chan, C L Chiang, K S H Chok, et al.
The Prostate|September 19, 2024
Deep PSA response and extended time-to-nadir as robust predictors of survival in Asian patients with de novo metastatic hormone-sensitive prostate cancer receiving upfront intensified treatmentChris H-M Wong, Ivan C-H Ko, David K-W Leung, et al.
Progress in Retinal and Eye Research|July 27, 2026
Retinal Manifestations of Alzheimer's Disease: Insights from Animal Models, Clinical Detection, and Future TranslationXiayin Zhang, Dongli Zhuang, Chunran Lai, et al.
Human Genetics|May 14, 1999
Molecular characterization of germline mutations in the BRCA1 and BRCA2 genes from breast cancer families in TaiwanS S Li, H M Tseng, T P Yang, et al.
European Journal of Neurology|December 9, 2010
Operational definitions improve reliability of the age-related white matter changes scaleY Xiong, J Yang, A Wong, et al.
Journal of the Neurological Sciences|October 21, 2019
Can transcranial Doppler ultrasound be used for screening cerebral small vessel diseases in the community?Di Kang, Adrian Wong, Jianhui Fu, et al.
Nature Communications|September 5, 2020
Pharmacologically reversible zonation-dependent endothelial cell transcriptomic changes with neurodegenerative disease associations in the aged brainLei Zhao, Zhongqi Li, Joaquim S L Vong, et al.
Hong Kong Medical Journal = Xianggang Yi Xue Za Zhi|June 17, 2026
Incidence and predictors of radiation proctitis or radiation cystitis after radiotherapy in patients with prostate cancerI C H Ko, C H T Mok, D K W Leung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 21, 2017
Afatinib versus gefitinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: overall survival data from the phase IIb LUX-Lung 7 trialL Paz-Ares, E-H Tan, K O'Byrne, et al.
Pageof 35